We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 dividend stocks I’d buy and hold for the next 10 years

These two buy-and-hold shares may be worth hanging onto for the long haul.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Today, I’m looking at two dividend stocks to buy and hold for the long haul.

Severn Trent

When you’re looking for stocks to keep for the next 10 years, the business would have to possess a robust track record of returning value to shareholders, have a resilient business model and offer a long-term growth story.

Should you buy Assura Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

With these three criteria, Severn Trent (LSE: SVT) comes to my mind. As a regulated water utility company with a monopoly over its customers, it generates stable earnings that grow steadily with inflation. This enables the firm to pay growing dividends to shareholders year after year, which makes its shares so attractive for investors looking for an inflation-beating income.

Regulatory risk

On the downside, investors need be wary of regulatory risk. Every five years, Ofwat, the water regulator, reviews and decides how much water companies need to invest in their infrastructure, and the level of customers’ bills needed to achieve this.

In a draft methodology paper published earlier this month, the next industry price review (PR19) looks set to be tougher than before. Ofwat is expecting to see significant improvement in affordability, customer service and innovation.

However, Severn Trent is also encouraged by the proposed changes to how good performing companies will be rewarded, as Ofwat is set to sharpen incentives for innovation by uncapping customer Outcome Delivery Incentive (ODI) rewards and increasing the role of cost sharing.

The firm has embraced the ODI regime, and is well placed to benefit from the changes as its comparative performance in the first two years of the current regulatory period has been encouraging. Its performance on water quality compliance and customer service is one of the highest in the industry, and as such, it expects to be well rewarded.

Near-term

In today’s trading update, the company upgraded guidance on its business services unit, and said it now expects both revenue and profit before interest and tax in this segment to grow on a like-for-like basis. In addition, the board continues to expect the company to deliver full-year trading performance in line with expectations and its prior guidance.

With shares currently trading at 18.4 times forward earnings and a prospective yield of 3.9% this year, Severn Trent seems to me reasonably valued.

Assura

Looking elsewhere, I reckon that healthcare property-rental company Assura (LSE: AGR) is another great long-term income play. The REIT is the largest primary care property investor and developer in the UK, with 422 medical centres and a total annualised rent roll of £76.9m.

While the healthcare property sector is not immune to macroeconomic risks, the sector is somewhat shielded by a chronic shortage of suitable properties and the non-cyclical nature of demand for healthcare. What’s more, Assura benefits from long lease terms, with an average unexpired lease term of 13.1 years, and inflation-linked leases, which offer it significant protection against a potential downturn.

In Tuesday’s trading update, the company announced that it had achieved a weighted average annual rent increase of 2.07% from 36 reviews settled in the three months to 30 June 2017. Looking ahead, it is set to grow its portfolio with £146m worth of new rental assets coming from acquisitions and new developments.

Shares in Assura currently trade at a 25% premium to its NAV, with a trailing yield of 3.7%.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A row of satellite radars at night
Investing Articles

This ex-penny stock has crushed Rolls-Royce shares over 5 years! Is there more to come?

With all eyes on Rolls-Royce shares, this growth share with a connection to SpaceX might have gone unnoticed by a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »